Annual CFO
-$8.56 M
+$12.56 M+59.47%
31 December 2023
Summary:
Ampio Pharmaceuticals annual cash flow from operations is currently -$8.56 million, with the most recent change of +$12.56 million (+59.47%) on 31 December 2023. During the last 3 years, it has risen by +$6.17 million (+41.86%). AMPE annual CFO is now -856300.00% below its all-time high of -$1000.00, reached on 31 December 2006.AMPE Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$2.31 M
-$1.75 M-316.04%
31 December 2023
Summary:
Ampio Pharmaceuticals quarterly cash flow from operations is currently -$2.31 million, with the most recent change of -$1.75 million (-316.04%) on 31 December 2023. Over the past year, it has dropped by -$1.75 million (-316.04%).AMPE Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$8.56 M
+$1.99 M+18.82%
31 December 2023
Summary:
Ampio Pharmaceuticals TTM cash flow from operations is currently -$8.56 million, with the most recent change of +$1.99 million (+18.82%) on 31 December 2023. Over the past year, it has increased by +$1.99 million (+18.82%).AMPE TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMPE Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +59.5% | -316.0% | +18.8% |
| 3 y3 years | +41.9% | +41.0% | +35.4% |
| 5 y5 years | +29.4% | +51.3% | +33.9% |
AMPE Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +59.5% | -316.0% | +61.2% | at high | +59.5% |
| 5 y | 5 years | at high | +59.5% | -316.0% | +61.2% | at high | +59.5% |
| alltime | all time | <-9999.0% | +72.1% | <-9999.0% | +76.3% | <-9999.0% | +72.1% |
Ampio Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$8.56 M(-59.5%) | -$2.31 M(+316.0%) | -$8.56 M(-18.8%) |
| Sept 2023 | - | -$555.00 K(-83.7%) | -$10.55 M(-33.8%) |
| June 2023 | - | -$3.40 M(+47.7%) | -$15.94 M(-13.8%) |
| Mar 2023 | - | -$2.30 M(-46.4%) | -$18.48 M(-12.5%) |
| Dec 2022 | -$21.13 M(+50.0%) | -$4.29 M(-27.7%) | -$21.13 M(+2.9%) |
| Sept 2022 | - | -$5.94 M(-0.1%) | -$20.54 M(+11.0%) |
| June 2022 | - | -$5.95 M(+20.3%) | -$18.50 M(+24.3%) |
| Mar 2022 | - | -$4.94 M(+33.5%) | -$14.89 M(+5.7%) |
| Dec 2021 | -$14.09 M(-4.3%) | -$3.70 M(-5.3%) | -$14.09 M(+6.2%) |
| Sept 2021 | - | -$3.91 M(+68.0%) | -$13.27 M(+10.0%) |
| June 2021 | - | -$2.33 M(-43.9%) | -$12.06 M(-15.8%) |
| Mar 2021 | - | -$4.15 M(+44.0%) | -$14.32 M(-2.8%) |
| Dec 2020 | -$14.73 M(-4.3%) | -$2.88 M(+6.4%) | -$14.73 M(-11.3%) |
| Sept 2020 | - | -$2.71 M(-41.0%) | -$16.60 M(-10.9%) |
| June 2020 | - | -$4.59 M(+0.8%) | -$18.63 M(+6.5%) |
| Mar 2020 | - | -$4.55 M(-4.2%) | -$17.50 M(+13.7%) |
| Dec 2019 | -$15.38 M(+26.7%) | -$4.75 M(+0.3%) | -$15.38 M(+18.7%) |
| Sept 2019 | - | -$4.74 M(+37.2%) | -$12.96 M(+13.4%) |
| June 2019 | - | -$3.45 M(+41.6%) | -$11.43 M(+4.2%) |
| Mar 2019 | - | -$2.44 M(+4.9%) | -$10.97 M(-9.6%) |
| Dec 2018 | -$12.14 M(+6.4%) | -$2.33 M(-27.5%) | -$12.14 M(-2.0%) |
| Sept 2018 | - | -$3.21 M(+7.1%) | -$12.38 M(+0.7%) |
| June 2018 | - | -$3.00 M(-16.8%) | -$12.30 M(-0.7%) |
| Mar 2018 | - | -$3.60 M(+40.1%) | -$12.39 M(+8.6%) |
| Dec 2017 | -$11.41 M(-22.0%) | -$2.57 M(-17.8%) | -$11.41 M(-0.1%) |
| Sept 2017 | - | -$3.13 M(+1.4%) | -$11.42 M(+5.9%) |
| June 2017 | - | -$3.09 M(+17.7%) | -$10.79 M(-12.8%) |
| Mar 2017 | - | -$2.62 M(+1.6%) | -$12.36 M(-15.5%) |
| Dec 2016 | -$14.63 M(-44.7%) | -$2.58 M(+3.3%) | -$14.63 M(-26.2%) |
| Sept 2016 | - | -$2.50 M(-46.4%) | -$19.81 M(-15.9%) |
| June 2016 | - | -$4.66 M(-4.5%) | -$23.56 M(-3.1%) |
| Mar 2016 | - | -$4.88 M(-37.1%) | -$24.32 M(-8.0%) |
| Dec 2015 | -$26.44 M | -$7.77 M(+24.3%) | -$26.44 M(+8.2%) |
| Sept 2015 | - | -$6.25 M(+15.2%) | -$24.44 M(-2.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2015 | - | -$5.43 M(-22.6%) | -$24.95 M(-14.7%) |
| Mar 2015 | - | -$7.01 M(+21.5%) | -$29.26 M(-4.8%) |
| Dec 2014 | -$30.74 M(+60.7%) | -$5.76 M(-14.7%) | -$30.74 M(+2.5%) |
| Sept 2014 | - | -$6.76 M(-30.6%) | -$29.98 M(+4.8%) |
| June 2014 | - | -$9.73 M(+14.7%) | -$28.62 M(+19.2%) |
| Mar 2014 | - | -$8.48 M(+69.5%) | -$24.01 M(+25.5%) |
| Dec 2013 | -$19.13 M(+96.9%) | -$5.01 M(-7.2%) | -$19.13 M(+14.4%) |
| Sept 2013 | - | -$5.39 M(+5.1%) | -$16.73 M(+26.4%) |
| June 2013 | - | -$5.13 M(+42.2%) | -$13.24 M(+29.6%) |
| Mar 2013 | - | -$3.61 M(+38.8%) | -$10.21 M(+5.1%) |
| Dec 2012 | -$9.72 M(+6.4%) | -$2.60 M(+36.5%) | -$9.72 M(-13.6%) |
| Sept 2012 | - | -$1.90 M(-9.6%) | -$11.25 M(+3.5%) |
| June 2012 | - | -$2.11 M(-32.2%) | -$10.87 M(+4.0%) |
| Mar 2012 | - | -$3.11 M(-24.8%) | -$10.45 M(+14.5%) |
| Dec 2011 | -$9.13 M(+247.4%) | -$4.13 M(+170.4%) | -$9.13 M(+59.0%) |
| Sept 2011 | - | -$1.53 M(-9.2%) | -$5.74 M(+18.4%) |
| June 2011 | - | -$1.68 M(-5.8%) | -$4.85 M(+28.9%) |
| Mar 2011 | - | -$1.79 M(+140.1%) | -$3.76 M(+43.1%) |
| Dec 2010 | -$2.63 M(+91.6%) | -$744.00 K(+17.3%) | -$2.63 M(+12.7%) |
| Sept 2010 | - | -$634.20 K(+6.6%) | -$2.33 M(+6.8%) |
| June 2010 | - | -$595.10 K(-9.1%) | -$2.18 M(+8.2%) |
| Mar 2010 | - | -$655.00 K(+46.1%) | -$2.02 M(+47.2%) |
| Dec 2009 | -$1.37 M(+3529.4%) | -$448.40 K(-7.8%) | -$1.37 M(+47.4%) |
| Sept 2009 | - | -$486.20 K(+13.1%) | -$930.40 K(+107.6%) |
| June 2009 | - | -$429.80 K(+5708.1%) | -$448.10 K(+1408.8%) |
| Mar 2009 | - | -$7400.00(+5.7%) | -$29.70 K(-21.4%) |
| Dec 2008 | -$37.80 K(+106.6%) | -$7000.00(+79.5%) | -$37.80 K(-1.8%) |
| Sept 2008 | - | -$3900.00(-65.8%) | -$38.50 K(+9.1%) |
| June 2008 | - | -$11.40 K(-26.5%) | -$35.30 K(+4.4%) |
| Mar 2008 | - | -$15.50 K(+101.3%) | -$33.80 K(+84.7%) |
| Dec 2007 | -$18.30 K(+1730.0%) | -$7700.00(+1000.0%) | -$18.30 K(+72.6%) |
| Sept 2007 | - | -$700.00(-92.9%) | -$10.60 K(+7.1%) |
| June 2007 | - | -$9900.00(<-9900.0%) | -$9900.00(<-9900.0%) |
| Mar 2007 | - | $0.00 | $0.00 |
| Dec 2006 | -$1000.00 | - | - |
FAQ
- What is Ampio Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals annual CFO year-on-year change?
- What is Ampio Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals quarterly CFO year-on-year change?
- What is Ampio Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals TTM CFO year-on-year change?
What is Ampio Pharmaceuticals annual cash flow from operations?
The current annual CFO of AMPE is -$8.56 M
What is the all time high annual CFO for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high annual cash flow from operations is -$1000.00
What is Ampio Pharmaceuticals annual CFO year-on-year change?
Over the past year, AMPE annual cash flow from operations has changed by +$12.56 M (+59.47%)
What is Ampio Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of AMPE is -$2.31 M
What is the all time high quarterly CFO for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high quarterly cash flow from operations is $0.00
What is Ampio Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, AMPE quarterly cash flow from operations has changed by -$1.75 M (-316.04%)
What is Ampio Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of AMPE is -$8.56 M
What is the all time high TTM CFO for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high TTM cash flow from operations is $0.00
What is Ampio Pharmaceuticals TTM CFO year-on-year change?
Over the past year, AMPE TTM cash flow from operations has changed by +$1.99 M (+18.82%)